GENOWAY has a total of 27 patent applications. Its first patent ever was published in 2001. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and Canada. Its main competitors in its focus markets biotechnology, agriculture and pharmaceuticals are ORIGEN THERAPEUTICS, TSI CORP and BEIJING SINOGENE BIOTECHNOLOGY CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 9 | |
#2 | EPO (European Patent Office) | 6 | |
#3 | Canada | 5 | |
#4 | France | 5 | |
#5 | Australia | 1 | |
#6 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Agriculture | |
#3 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Animal care | |
#3 | Peptides | |
#4 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Fraichard Alexandre | 23 |
#2 | Thiam Kader | 19 |
#3 | Bertaux Fabien | 9 |
#4 | Lapize-Gauthey Christine | 6 |
#5 | Rattis Frederique | 5 |
#6 | Cherifi Yacine | 5 |
#7 | Lagardette Florence | 4 |
#8 | Lapize Chritine | 2 |
#9 | Lapize Christine | 2 |
#10 | Lapize Gauthey Christine | 1 |
Publication | Filing date | Title |
---|---|---|
WO2006048465A2 | Animal models comprising at least one mutation or one conditional ki and one conditional ko | |
WO2006048467A2 | Animal models comprising at least one transgene and one sequence enabling the controlled expression of an rna interfering with this transgene | |
WO2006048464A2 | Expressing heterologous genes in a specific manner in certain tissues of transgenic animal models | |
FR2827302A1 | TRANSGENIC CELL AND ANIMAL MODELING HUMAN ANTIGENIC PRESENTATION AND USES THEREOF | |
FR2825103A1 | CLONING VECTORS FOR APPROVED RECOMBINATION AND METHOD OF USING THE SAME | |
FR2824844A1 | DUAL SELECTION CLONING PROCESS AND VECTORS THEREFOR | |
FR2822161A1 | TRANSGENIC CELL AND ANIMAL MODELING IGE MEDIATED ALLERGIC RESPONSES AND USES THEREOF | |
FR2821854A1 | TRANSGENIC CELLS AND ANIMALS FOR STUDYING POLARIZATION OF THE IMMUNE RESPONSE |